Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage

MOspace/Manakin Repository

Breadcrumbs Navigation

Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage

Please use this identifier to cite or link to this item: http://dx.doi.org/10.1186/1471-2202-11-125

[+] show full item record


Title: Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage
Author: Tulsawani, Rajkumar; Kelly, Lorena S; Fatma, Nigar; Chhunchha, Bhavanaben; Kubo, Eri; Kumar, Anil; Singh, Dhirendra P
Date: 2010-10-05
Citation: BMC Neuroscience. 2010 Oct 05;11(1):125
Abstract: Abstract Background The ability to respond to changes in the extra-intracellular environment is prerequisite for cell survival. Cellular responses to the environment include elevating defense systems, such as the antioxidant defense system. Hypoxia-evoked reactive oxygen species (ROS)-driven oxidative stress is an underlying mechanism of retinal ganglion cell (RGC) death that leads to blinding disorders. The protein peroxiredoxin 6 (PRDX6) plays a pleiotropic role in negatively regulating death signaling in response to stressors, and thereby stabilizes cellular homeostasis. Results We have shown that RGCs exposed to hypoxia (1%) or hypoxia mimetic cobalt chloride display reduced expression of PRDX6 with higher ROS expression and activation of NF-κB. These cells undergo apoptosis, while cells with over-expression of PRDX6 demonstrate resistance against hypoxia-driven RGC death. The RGCs exposed to hypoxia either with 1% oxygen or cobalt chloride (0-400 μM), revealed ~30%-70% apoptotic cell death after 48 and 72 h of exposure. Western analysis and real-time PCR showed elevated expression of PRDX6 during hypoxia at 24 h, while PRDX6 protein and mRNA expression declined from 48 h onwards following hypoxia exposure. Concomitant with this, RGCs showed increased ROS expression and activation of NF-κB with IkB phosphorylation/degradation, as examined with H2DCF-DA and transactivation assays. These hypoxia-induced adverse reactions could be reversed by over-expression of PRDX6. Conclusion Because an abundance of PRDX6 in cells was able to attenuate hypoxia-induced RGC death, the protein could possibly be developed as a novel therapeutic agent acting to postpone RGC injury and delay the progression of glaucoma and other disorders caused by the increased-ROS-generated death signaling related to hypoxia.
URI: http://dx.doi.org/10.1186/1471-2202-11-125
http://hdl.handle.net/10355/15015

This item appears in the following Collection(s)

[+] show full item record